𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Assessment of the bioequivalence of brand and biogeneric formulations of abciximab for the treatment of acute coronary syndrome: A prospective, open-label, randomized, controlled study in Korean patients

✍ Scribed by Dong-Hyun Choi; Jung-Won Suh; Kyung-Woo Park; Hyun-Jae Kang; Hyo-Soo Kim


Book ID
113544029
Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
123 KB
Volume
31
Category
Article
ISSN
0149-2918

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES